Form 4: Cullinan Therapeutics' Chief Scientific Officer Sells Shares to Cover Tax Obligations

Jennifer Michaelson, Chief Scientific Officer of Cullinan Therapeutics, sold 4,693 shares of common stock on December 18, 2024, to cover personal income tax obligations.

Summary

• On December 18, 2024, Jennifer Michaelson, the Chief Scientific Officer of Cullinan Therapeutics, sold 4,693 shares of the company's common stock.
• The shares were sold at a price of $11.41 per share.
• The transaction was executed to cover personal income tax obligations arising from the vesting of restricted stock units.
• Following the transaction, Michaelson directly owns 99,760 shares of Cullinan Therapeutics.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing simply reports a stock sale for tax purposes, which is a routine event. It doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This sale appears to be related to tax obligations, which is a common reason for such transactions.

Stakeholder Impact

• The sale of shares by an insider could have a minor negative impact on shareholder sentiment, although it is likely to be minimal given the stated reason for the sale.

Key Dates